 <h1>Xifaxan Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>rifaximin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about rifaximin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Xifaxan.</p><h2>In Summary</h2><p><b>Common side effects of Xifaxan include:</b> flatulence. <b>Other side effects include:</b> abdominal pain, bowel urgency, headache, nausea, and rectal tenesmus.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to rifaximin: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, rifaximin (the active ingredient contained in Xifaxan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking rifaximin:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>dizziness or lightheadedness</li>
<li>muscle spasm</li>
<li>rapid breathing</li>
<li>shortness of breath</li>
<li>trouble sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blood in the urine</li>
<li>bloody nose</li>
<li>chest pain</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>fainting</li>
<li>feeling of constant movement of self or surroundings</li>
<li>increased heart rate</li>
<li>sensation of spinning</li>
<li>sunken eyes</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Cracks in the skin</li>
<li>hives or welts, itching skin, or rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of heat from the body</li>
<li>red, swollen skin</li>
<li>redness of the skin</li>
<li>scaly skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of rifaximin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bloated</li>
<li>difficulty with moving</li>
<li>excess air or gas in the stomach or intestines</li>
<li>fever</li>
<li>frequent urge to defecate</li>
<li>full feeling</li>
<li>headache</li>
<li>lower back or side pain</li>
<li>muscle pain or stiffness</li>
<li>pain in the joints</li>
<li>passing gas</li>
<li>stomach pain</li>
<li>straining while passing stool</li>
<li>swelling of the hands, ankles, feet, or lower legs</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal dreams</li>
<li>blurred vision</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>decreased urination</li>
<li>difficulty having a bowel movement (stool)</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry lips</li>
<li>dry mouth</li>
<li>ear pain</li>
<li>feeling of warmth</li>
<li>hearing loss</li>
<li>lightheadedness</li>
<li>loss of appetite</li>
<li>loss of taste</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>sore throat</li>
<li>sweating</li>
<li>swollen glands</li>
<li>thirst</li>
<li>vomiting</li>
<li>wrinkled skin</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rifaximin: oral tablet</i></p><h3>General</h3><p>When used for the treatment of travelers' diarrhea, the most common side effect was headache.  This drug was discontinued due to side effects in 0.4% of patients; such side effects were taste loss, dysentery, decreased weight, anorexia, nausea, and nasal passage irritation.</p>
<p></p>
<p>When used for reduction in risk of overt hepatic encephalopathy recurrence, the most common side effects were peripheral edema, nausea, dizziness, fatigue, and ascites.</p>
<p></p>
<p>When used for the treatment of irritable bowel syndrome with diarrhea, the most common side effects were nausea and increased ALT.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 14.3%), ascites (11.4%), flatulence (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, abdominal distension, rectal tenesmus, upper abdominal pain, defecation urgency, constipation, stomach discomfort, vomiting, lower abdominal pain, abdominal tenderness, dry mouth, esophageal variceal bleed, diarrhea, bloating and distension, nausea and vomiting symptoms</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry lips, dyspepsia, gastrointestinal motility disorder, hard feces, hematochezia, mucous stools, taste disorders</p>
<p><b>Frequency not reported</b>: Blood in stool, dysentery, fecal abnormality, gingival disorder, inguinal hernia, straining, bad taste in mouth, Clostridium colitis</p>
<p><b>Postmarketing reports</b>: Clostridium difficile-associated colitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Peripheral edema (15%), fatigue (up to 12.1%)</p>
<p><b>Common</b> (1% to 10%): Pyrexia, chest pain, pain, generalized edema, influenza-like illness, contusion, fall, procedural pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Ear pain, clostridial infection, candidiasis, hot flush, edema, herpes simplex, asthenic conditions, chills, pain and discomfort</p>
<p><b>Rare</b> (less than 0.1%): Asthenia</p>
<p><b>Frequency not reported</b>: Motion sickness, malaise, hot flashes</p>
<p><b>Postmarketing reports</b>: Clostridial infections (Clostridium difficile)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 13%), headache (10%)</p>
<p><b>Common</b> (1% to 10%): Vertigo, amnesia, disturbance in attention, hypoesthesia, memory impairment, tremor</p>
<p><b>Uncommon</b> (0.1% to 1%): Balance disorders, convulsion, attention disorders, migraine, paresthesia, sinus headache, somnolence</p>
<p><b>Frequency not reported</b>: Syncope, tinnitus, loss of taste</p>
<p><b>Postmarketing reports</b>: Presyncope, syncope<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reactions</p>
<p><b>Postmarketing reports</b>: Hypersensitivity reactions (including exfoliative dermatitis, rash, angioneurotic edema [swelling of face and tongue and difficulty swallowing], urticaria, pruritus, flushing, anaphylaxis), anaphylactic responses, angioedemas, hypersensitivity<sup>[Ref]</sup></p><p>Hypersensitivity reactions have occurred as early as within 15 minutes of drug administration.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, cellulitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Eruptions and exanthemas, sunburn, hyperhidrosis/increased sweating, cold sweat</p>
<p><b>Frequency not reported</b>: Clamminess</p>
<p><b>Postmarketing reports</b>: Dermatitis, eczema, erythemas, pruritus, purpura, urticarias<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms, arthralgia, back pain, myalgia, pain in extremity</p>
<p><b>Uncommon</b> (0.1% to 1%): Neck pain, muscular weakness</p>
<p><b>Frequency not reported</b>: Increased blood creatine phosphokinase<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Lymphocytosis, monocytosis, neutropenia</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia, INR abnormalities<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, nasopharyngitis, dyspnea, upper respiratory tract infection, rhinitis, pneumonia, epistaxis</p>
<p><b>Uncommon</b> (0.1% to 1%): Pleural effusion, pharyngitis, oropharyngeal pain, rhinorrhea, dry throat, nasal congestion</p>
<p><b>Rare</b> (less than 0.1%): Chronic obstructive pulmonary disease</p>
<p><b>Frequency not reported</b>: Respiratory tract infection, nasal passage irritation, pharyngolaryngeal pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia, confusional state</p>
<p><b>Uncommon</b> (0.1% to 1%): Anxiety, hypersomnia, abnormal dreams, depressed mood, nervousness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Increased weight, anorexia, dehydration, hyperglycemia, hyperkalemia, hypoglycemia, hyponatremia</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased appetite</p>
<p><b>Frequency not reported</b>: Decreased weight<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension</p>
<p><b>Uncommon</b> (0.1% to 1%): Palpitations, increased blood pressure</p>
<p><b>Rare</b> (less than 0.1%): Hypertension<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection, dysuria, polyuria, proteinuria, pollakiuria, blood in urine present, glycosuria, polymenorrhea</p>
<p><b>Frequency not reported</b>: Choluria, hematuria, urinary frequency<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased AST</p>
<p><b>Postmarketing reports</b>: Liver function test abnormalities<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Diplopia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Xifaxan (rifaximin)." Salix Pharmaceuticals, Raleigh, NC. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Juillerat P,  Pittet V,  Felley C, et al. "Drug safety in Crohn's disease therapy." Digestion 76 (2007): 161-8</p><p id="ref_5">5. Pimentel M,  Park S,  Mirocha J,  Kane SV,  Kong Y "The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial." Ann Intern Med 145 (2006): 557-63</p><p id="ref_6">6. Trapnell CB,  Connolly M,  Pentikis H,  Forbes B,  Bettenhausen DK "Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females." Ann Pharmacother 41 (2007): 222-8</p><p id="ref_7">7. "Rifaximin (Xifaxan 550) for hepatic encephalopathy." Med Lett Drugs Ther 52 (2010): 87</p><p id="ref_8">8. Garey KW,  Salazar M,  Shah D,  Rodrigue R,  Dupont HL "Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea." Ann Pharmacother 42 (2008): 827-35</p><p id="ref_9">9. Hynicka LM,  Silva KN "Probable rifaximin-induced neutropenia." Am J Health Syst Pharm 69 (2012): 583-6</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Xifaxan (rifaximin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>72 Reviews</li>
<li>Drug class: miscellaneous antibiotics</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xifaxan &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hepatic Encephalopathy</li>
<li>Irritable Bowel Syndrome</li>
<li>Traveler's Diarrhea</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rifaximin: oral tablet</i></p><h3>General</h3><p>When used for the treatment of travelers' diarrhea, the most common side effect was headache.  This drug was discontinued due to side effects in 0.4% of patients; such side effects were taste loss, dysentery, decreased weight, anorexia, nausea, and nasal passage irritation.</p><p></p><p>When used for reduction in risk of overt hepatic encephalopathy recurrence, the most common side effects were peripheral edema, nausea, dizziness, fatigue, and ascites.</p><p></p><p>When used for the treatment of irritable bowel syndrome with diarrhea, the most common side effects were nausea and increased ALT.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 14.3%), ascites (11.4%), flatulence (up to 11%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, abdominal distension, rectal tenesmus, upper abdominal pain, defecation urgency, constipation, stomach discomfort, vomiting, lower abdominal pain, abdominal tenderness, dry mouth, esophageal variceal bleed, diarrhea, bloating and distension, nausea and vomiting symptoms</p><p><b>Uncommon</b> (0.1% to 1%): Dry lips, dyspepsia, gastrointestinal motility disorder, hard feces, hematochezia, mucous stools, taste disorders</p><p><b>Frequency not reported</b>: Blood in stool, dysentery, fecal abnormality, gingival disorder, inguinal hernia, straining, bad taste in mouth, Clostridium colitis</p><p><b>Postmarketing reports</b>: Clostridium difficile-associated colitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Peripheral edema (15%), fatigue (up to 12.1%)</p><p><b>Common</b> (1% to 10%): Pyrexia, chest pain, pain, generalized edema, influenza-like illness, contusion, fall, procedural pain</p><p><b>Uncommon</b> (0.1% to 1%): Ear pain, clostridial infection, candidiasis, hot flush, edema, herpes simplex, asthenic conditions, chills, pain and discomfort</p><p><b>Rare</b> (less than 0.1%): Asthenia</p><p><b>Frequency not reported</b>: Motion sickness, malaise, hot flashes</p><p><b>Postmarketing reports</b>: Clostridial infections (Clostridium difficile)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 13%), headache (10%)</p><p><b>Common</b> (1% to 10%): Vertigo, amnesia, disturbance in attention, hypoesthesia, memory impairment, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Balance disorders, convulsion, attention disorders, migraine, paresthesia, sinus headache, somnolence</p><p><b>Frequency not reported</b>: Syncope, tinnitus, loss of taste</p><p><b>Postmarketing reports</b>: Presyncope, syncope<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reactions</p><p><b>Postmarketing reports</b>: Hypersensitivity reactions (including exfoliative dermatitis, rash, angioneurotic edema [swelling of face and tongue and difficulty swallowing], urticaria, pruritus, flushing, anaphylaxis), anaphylactic responses, angioedemas, hypersensitivity<sup>[Ref]</sup></p><p>Hypersensitivity reactions have occurred as early as within 15 minutes of drug administration.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, cellulitis</p><p><b>Uncommon</b> (0.1% to 1%): Eruptions and exanthemas, sunburn, hyperhidrosis/increased sweating, cold sweat</p><p><b>Frequency not reported</b>: Clamminess</p><p><b>Postmarketing reports</b>: Dermatitis, eczema, erythemas, pruritus, purpura, urticarias<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms, arthralgia, back pain, myalgia, pain in extremity</p><p><b>Uncommon</b> (0.1% to 1%): Neck pain, muscular weakness</p><p><b>Frequency not reported</b>: Increased blood creatine phosphokinase<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p><p><b>Uncommon</b> (0.1% to 1%): Lymphocytosis, monocytosis, neutropenia</p><p><b>Postmarketing reports</b>: Thrombocytopenia, INR abnormalities<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, nasopharyngitis, dyspnea, upper respiratory tract infection, rhinitis, pneumonia, epistaxis</p><p><b>Uncommon</b> (0.1% to 1%): Pleural effusion, pharyngitis, oropharyngeal pain, rhinorrhea, dry throat, nasal congestion</p><p><b>Rare</b> (less than 0.1%): Chronic obstructive pulmonary disease</p><p><b>Frequency not reported</b>: Respiratory tract infection, nasal passage irritation, pharyngolaryngeal pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia, confusional state</p><p><b>Uncommon</b> (0.1% to 1%): Anxiety, hypersomnia, abnormal dreams, depressed mood, nervousness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Increased weight, anorexia, dehydration, hyperglycemia, hyperkalemia, hypoglycemia, hyponatremia</p><p><b>Uncommon</b> (0.1% to 1%): Decreased appetite</p><p><b>Frequency not reported</b>: Decreased weight<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension</p><p><b>Uncommon</b> (0.1% to 1%): Palpitations, increased blood pressure</p><p><b>Rare</b> (less than 0.1%): Hypertension<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection, dysuria, polyuria, proteinuria, pollakiuria, blood in urine present, glycosuria, polymenorrhea</p><p><b>Frequency not reported</b>: Choluria, hematuria, urinary frequency<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT</p><p><b>Uncommon</b> (0.1% to 1%): Increased AST</p><p><b>Postmarketing reports</b>: Liver function test abnormalities<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Diplopia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Xifaxan (rifaximin)." Salix Pharmaceuticals, Raleigh, NC. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Juillerat P,  Pittet V,  Felley C, et al. "Drug safety in Crohn's disease therapy." Digestion 76 (2007): 161-8</p><p id="ref_5">5. Pimentel M,  Park S,  Mirocha J,  Kane SV,  Kong Y "The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial." Ann Intern Med 145 (2006): 557-63</p><p id="ref_6">6. Trapnell CB,  Connolly M,  Pentikis H,  Forbes B,  Bettenhausen DK "Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females." Ann Pharmacother 41 (2007): 222-8</p><p id="ref_7">7. "Rifaximin (Xifaxan 550) for hepatic encephalopathy." Med Lett Drugs Ther 52 (2010): 87</p><p id="ref_8">8. Garey KW,  Salazar M,  Shah D,  Rodrigue R,  Dupont HL "Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea." Ann Pharmacother 42 (2008): 827-35</p><p id="ref_9">9. Hynicka LM,  Silva KN "Probable rifaximin-induced neutropenia." Am J Health Syst Pharm 69 (2012): 583-6</p><h2>More about Xifaxan (rifaximin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>72 Reviews</li>
<li>Drug class: miscellaneous antibiotics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xifaxan &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hepatic Encephalopathy</li>
<li>Irritable Bowel Syndrome</li>
<li>Traveler's Diarrhea</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>